Showing 1 - 7 results of 7 for search 'Ulf Mueller-Ladner', query time: 0.04s Refine Results
  1. 1
    TNFi is associated with positive outcome, but JAKi and rituximab are associated with negative outcome of SARS-CoV-2 infection in patients with RMD

    TNFi is associated with positive outcome, but JAKi and rituximab are associated with negative outcome of SARS-CoV-2 infection in patients with RMD by Ulf Mueller-Ladner, Hendrik Schulze-Koops, Tim Schmeiser, Hanns-Martin Lorenz, Christof Specker, Reinhard E Voll, Bimba F Hoyer, Jutta Richter, Alexander Pfeil, Rebecca Hasseli, Andreas Krause, Anne Constanze Regierer, Martin Schäfer

    Published 2021-11-01
    Get full text
    Article
  2. 2
    Point of view on the vaccination against COVID-19 in patients with autoimmune inflammatory rheumatic diseases

    Point of view on the vaccination against COVID-19 in patients with autoimmune inflammatory rheumatic diseases by Ulf Mueller-Ladner, Karen Schreiber, Nico M Wulffraat, Victoria Furer, Christien Rondaan, Nancy Agmon-Levin, Sander van Assen, Marc Bijl, Meliha Crnkic Kapetanovic, Klaus Warnatz, Ori Elkayam, Annette de Thurah, Daphna Paran

    Published 2021-04-01
    Get full text
    Article
  3. 3
    National registry for patients with inflammatory rheumatic diseases (IRD) infected with SARS-CoV-2 in Germany (ReCoVery): a valuable mean to gain rapid and reliable knowledge of the clinical course of SARS-CoV-2 infections in patients with IRD

    National registry for patients with inflammatory rheumatic diseases (IRD) infected with SARS-CoV-2 in Germany (ReCoVery): a valuable mean to gain rapid and reliable knowledge of th... by Ulf Mueller-Ladner, Hendrik Schulze-Koops, Tim Schmeiser, Jutta G Richter, Hanns-Martin Lorenz, Christof Specker, Reinhard E Voll, Anja Strangfeld, Bimba F Hoyer, Alexander Pfeil, Rebecca Hasseli, Andreas Krause, Anne Constanze Regierer

    Published 2020-08-01
    Get full text
    Article
  4. 4
    Older age, comorbidity, glucocorticoid use and disease activity are risk factors for COVID-19 hospitalisation in patients with inflammatory rheumatic and musculoskeletal diseases

    Older age, comorbidity, glucocorticoid use and disease activity are risk factors for COVID-19 hospitalisation in patients with inflammatory rheumatic and musculoskeletal diseases by Ulf Mueller-Ladner, Hendrik Schulze-Koops, Tim Schmeiser, Hanns-Martin Lorenz, Christof Specker, Reinhard E Voll, Anja Strangfeld, Bimba F Hoyer, Jutta Richter, Alexander Pfeil, Rebecca Hasseli, Andreas Krause, Anne Constanze Regierer, Martin Schäfer

    Published 2021-04-01
    Get full text
    Article
  5. 5
    Clinical practice guidelines adherence, knowledge and awareness in rare and complex connective tissue diseases across Europe: results from the first ERN ReCONNET survey

    Clinical practice guidelines adherence, knowledge and awareness in rare and complex connective tissue diseases across Europe: results from the first ERN ReCONNET survey by Rosaria Talarico, Frederic Houssiau, Stefano Bombardieri, Gerd Burmester, Ilaria Galetti, Eric Hachulla, Ulf Mueller-Ladner, Matthias Schneider, Vanessa Smith, Maurizio Cutolo, Marta Mosca, Jacob M van Laar, Charissa Frank, Ana Vieira, Giuseppe Turchetti, Joao Fonseca, Diana Marinello

    Published 2020-09-01
    Get full text
    Article
  6. 6
    Performance of the EULAR Systemic sclerosis Impact of Disease (ScleroID) questionnaire as a patient-reported outcome measure for patients with diffuse systemic sclerosis

    Performance of the EULAR Systemic sclerosis Impact of Disease (ScleroID) questionnaire as a patient-reported outcome measure for patients with diffuse systemic sclerosis by Ulf Mueller-Ladner, Marco Matucci-Cerinic, Oliver Distler, Cosimo Bruni, Otylia Kowal-Bielecka, Kim Fligelstone, Roger Hesselstrand, László Czirják, Carina Mihai, Gunnel Sandqvist, Rucsandra Dobrota, Patricia E Carreira, Ana Maria Gherghe, Tore Kvien, Turid Heiberg, Alexandru Garaiman, Mike Oliver Becker, Annelise Roennow, Ann Tyrrell Kennedy, Chris Denton

    Published 2024-12-01
    Get full text
    Article
  7. 7
    Systemic sclerosis associated interstitial lung disease - individualized immunosuppressive therapy and course of lung function: results of the EUSTAR group

    Systemic sclerosis associated interstitial lung disease - individualized immunosuppressive therapy and course of lung function: results of the EUSTAR group by Sabine Adler, Dörte Huscher, Elise Siegert, Yannick Allanore, László Czirják, Francesco DelGaldo, Christopher P. Denton, Oliver Distler, Marc Frerix, Marco Matucci-Cerinic, Ulf Mueller-Ladner, Ingo-Helmut Tarner, Gabriele Valentini, Ulrich A. Walker, Peter M. Villiger, Gabriela Riemekasten, EUSTAR co-workers on behalf of the DeSScipher project research group within the EUSTAR network

    Published 2018-01-01
    Get full text
    Article

Search Tools: